CN Stock MarketDetailed Quotes

300485 Beijing Science Sun Pharmaceutical

Watchlist
  • 7.79
  • +0.14+1.83%
Market Closed Nov 4 15:00 CST
3.75BMarket Cap-19572P/E (TTM)

Beijing Science Sun Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
-18.01%322.88M
-21.03%214.84M
-17.46%109.54M
-35.12%476.57M
-34.28%393.82M
-29.04%272.04M
-30.92%132.7M
-30.10%734.55M
-25.97%599.23M
-26.55%383.34M
Operating revenue
-18.01%322.88M
-21.03%214.84M
-17.46%109.54M
-35.12%476.57M
-34.28%393.82M
-29.04%272.04M
-30.92%132.7M
-30.10%734.55M
-25.97%599.23M
-26.55%383.34M
Other operating revenue
----
--164.69K
----
-20.81%646.39K
----
--0
----
-28.80%816.2K
----
-35.82%540.97K
Total operating cost
-18.60%304.13M
-21.08%205.07M
-20.30%103.93M
-27.15%517.65M
-33.39%373.63M
-27.99%259.86M
-23.50%130.4M
-24.81%710.54M
-21.57%560.94M
-22.59%360.86M
Operating cost
-2.20%110.22M
-3.17%74M
-2.40%37.16M
-17.87%140.94M
-18.92%112.7M
-13.95%76.43M
-12.08%38.08M
-5.77%171.61M
-11.83%139M
-11.90%88.81M
Operating tax surcharges
-8.86%4.27M
-9.09%3.64M
-18.86%712K
-16.24%7.4M
-41.61%4.68M
-12.56%4.01M
-73.90%877.46K
-24.74%8.83M
-20.98%8.02M
-21.74%4.58M
Operating expense
-30.98%112.6M
-30.64%77.33M
-19.90%43.32M
-37.53%230.43M
-44.56%163.16M
-41.55%111.49M
-42.19%54.08M
-33.56%368.84M
-31.18%294.3M
-31.43%190.73M
Administration expense
-2.83%38.39M
-0.51%25.77M
29.89%13.82M
1.84%62.2M
-2.14%39.51M
-6.18%25.9M
-21.19%10.64M
-40.97%61.07M
-15.51%40.38M
-9.81%27.61M
Financial expense
-120.91%-1.57M
-43.92%-490.56K
-220.60%-250.07K
-132.38%-1.05M
-130.21%-712.3K
-47.67%-340.87K
33.63%-78K
96.01%-451.3K
96.35%-309.42K
95.98%-230.83K
-Interest Income (Financial expense)
-108.95%-1.58M
-30.26%-499.36K
-192.01%-253.21K
-127.25%-1.1M
-125.98%-758.35K
-53.34%-383.35K
32.75%-86.71K
95.80%-485.66K
96.15%-335.58K
95.70%-249.99K
Research and development
-25.92%40.22M
-41.42%24.83M
-65.80%9.17M
-22.76%77.73M
-31.76%54.29M
-14.14%42.38M
59.10%26.8M
-3.09%100.63M
-1.14%79.56M
-12.62%49.36M
Credit Impairment Loss
378.17%601.24K
147.80%468.74K
-109.88%-644.12K
550.35%1.65M
-138.22%-216.15K
-1,807.96%-980.69K
1,605.94%6.52M
-76.01%253.23K
-102.09%-90.73K
-101.99%-51.4K
Asset Impairment Loss
----
----
----
--0
----
----
----
--0
----
----
Other net revenue
-171.49%-140.02M
-152.36%-138.92M
-201,417.47%-230.64M
-29.40%162.81M
-19.98%195.87M
12.59%265.34M
-99.88%114.57K
-30.79%230.63M
284.04%244.77M
546.67%235.67M
Fair value change income
-169.70%-86.94M
-153.93%-90.11M
-1,970.60%-148.13M
-20.05%100.27M
-11.96%124.73M
17.04%167.09M
-110.16%-7.15M
-32.45%125.41M
465.12%141.68M
560.31%142.76M
Invest income
-177.10%-54.86M
-150.88%-50.45M
-12,408.75%-82.97M
-31.03%59.81M
-21.41%71.15M
23.45%99.15M
-96.73%674.1K
-34.70%86.71M
208.29%90.53M
584.98%80.32M
-Including: Investment income associates
-215.61%-70.92M
-172.24%-65.85M
-2,382.06%-90.93M
-13.35%46.92M
-9.84%61.35M
30.04%91.16M
-120.91%-3.66M
-40.97%54.15M
14,620.73%68.04M
1,429.66%70.1M
Asset deal income
----
----
----
-99.96%2.54K
----
----
----
1.23%6.65M
52.26%6.65M
--6.65M
Other revenue
484.90%1.17M
1,368.34%1.17M
1,373.24%1.11M
-90.60%1.09M
-96.66%200.84K
-98.68%79.38K
-98.74%75.24K
62.30%11.61M
910.91%6.01M
1,060.15%6M
Operating profit
-156.13%-121.27M
-146.54%-129.16M
-9,424.25%-225.04M
-52.19%121.74M
-23.67%216.06M
7.50%277.51M
-98.00%2.41M
-42.00%254.64M
79.20%283.07M
179.92%258.16M
Add:Non operating Income
965.63%330.63K
358.86%130.22K
----
721.75%470.02K
-43.97%31.03K
15.06%28.38K
250.48%24.76K
-51.15%57.2K
-50.65%55.37K
-77.10%24.66K
Less:Non operating expense
3,016.88%566.77K
52,876.07%526.77K
1,065.87%1.1K
-44.43%43.17K
-76.59%18.18K
-60.95%994.35
-96.29%94.35
-15.61%77.68K
-34.81%77.68K
82.79%2.55K
Total profit
-156.23%-121.5M
-146.68%-129.56M
-9,329.95%-225.04M
-52.02%122.16M
-23.66%216.07M
7.50%277.54M
-97.98%2.44M
-42.00%254.62M
79.19%283.05M
179.62%258.18M
Less:Income tax cost
-184.68%-19.3M
-176.06%-21.29M
-1,709.22%-32.69M
-50.44%25.76M
-30.66%22.79M
9.49%27.99M
-86.58%2.03M
18.40%51.97M
31.45%32.86M
150.18%25.57M
Net profit
SL-102.21M
SL-108.26M
SL-192.35M
-52.43%96.41M
-22.74%193.29M
7.28%249.54M
-99.62%406.47K
-48.71%202.65M
88.17%250.18M
183.28%232.61M
Net profit from continuing operation
-152.88%-102.21M
-143.38%-108.26M
-47,421.38%-192.35M
-52.43%96.41M
-22.74%193.29M
7.28%249.54M
-99.62%406.47K
-48.71%202.65M
88.17%250.18M
183.28%232.61M
Less:Minority Profit
-23.70%-4.01M
-46.93%-3.11M
-314.00%-1.73M
-212.23%-6.51M
-32.65%-3.24M
-34.93%-2.12M
42.73%-417.47K
70.78%-2.09M
48.66%-2.44M
51.26%-1.57M
Net profit of parent company owners
-149.97%-98.2M
-141.78%-105.15M
-23,235.01%-190.62M
-49.73%102.92M
-22.21%196.53M
7.47%251.66M
-99.23%823.94K
-49.11%204.73M
83.44%252.62M
174.43%234.18M
Earning per share
Basic earning per share
-148.78%-0.2
-142.31%-0.22
-23,376.47%-0.3957
-51.16%0.21
-21.15%0.41
6.12%0.52
-99.23%0.0017
-48.81%0.43
79.31%0.52
172.22%0.49
Diluted earning per share
-148.78%-0.2
-142.31%-0.22
-23,376.47%-0.3957
-51.16%0.21
-21.15%0.41
6.12%0.52
-99.23%0.0017
-48.81%0.43
79.31%0.52
172.22%0.49
Other composite income
-135.49%-382.43K
-83.08%221.22K
113.28%61.7K
-79.89%591.67K
-70.21%1.08M
-22.01%1.31M
-238.16%-464.52K
494.73%2.94M
1,932.33%3.62M
617.81%1.68M
Other composite income of parent company owners
-135.49%-382.43K
-83.08%221.22K
113.28%61.7K
-79.89%591.67K
-70.21%1.08M
-22.01%1.31M
-238.16%-464.52K
494.73%2.94M
1,932.33%3.62M
617.81%1.68M
Total composite income
-152.78%-102.59M
-143.07%-108.04M
-331,112.04%-192.28M
-52.82%97M
-23.42%194.36M
7.07%250.85M
-100.05%-58.05K
-47.87%205.59M
91.17%253.8M
186.45%234.29M
Total composite income of parent company owners
-149.89%-98.58M
-141.48%-104.93M
-53,118.56%-190.56M
-50.16%103.51M
-22.88%197.6M
7.26%252.97M
-99.66%359.41K
-48.28%207.68M
86.33%256.24M
177.45%235.86M
Total composite income of minority owners
-23.70%-4.01M
-46.93%-3.11M
-314.00%-1.73M
-212.23%-6.51M
-32.65%-3.24M
-34.93%-2.12M
42.73%-417.47K
70.78%-2.09M
48.66%-2.44M
51.26%-1.57M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue -18.01%322.88M-21.03%214.84M-17.46%109.54M-35.12%476.57M-34.28%393.82M-29.04%272.04M-30.92%132.7M-30.10%734.55M-25.97%599.23M-26.55%383.34M
Operating revenue -18.01%322.88M-21.03%214.84M-17.46%109.54M-35.12%476.57M-34.28%393.82M-29.04%272.04M-30.92%132.7M-30.10%734.55M-25.97%599.23M-26.55%383.34M
Other operating revenue ------164.69K-----20.81%646.39K------0-----28.80%816.2K-----35.82%540.97K
Total operating cost -18.60%304.13M-21.08%205.07M-20.30%103.93M-27.15%517.65M-33.39%373.63M-27.99%259.86M-23.50%130.4M-24.81%710.54M-21.57%560.94M-22.59%360.86M
Operating cost -2.20%110.22M-3.17%74M-2.40%37.16M-17.87%140.94M-18.92%112.7M-13.95%76.43M-12.08%38.08M-5.77%171.61M-11.83%139M-11.90%88.81M
Operating tax surcharges -8.86%4.27M-9.09%3.64M-18.86%712K-16.24%7.4M-41.61%4.68M-12.56%4.01M-73.90%877.46K-24.74%8.83M-20.98%8.02M-21.74%4.58M
Operating expense -30.98%112.6M-30.64%77.33M-19.90%43.32M-37.53%230.43M-44.56%163.16M-41.55%111.49M-42.19%54.08M-33.56%368.84M-31.18%294.3M-31.43%190.73M
Administration expense -2.83%38.39M-0.51%25.77M29.89%13.82M1.84%62.2M-2.14%39.51M-6.18%25.9M-21.19%10.64M-40.97%61.07M-15.51%40.38M-9.81%27.61M
Financial expense -120.91%-1.57M-43.92%-490.56K-220.60%-250.07K-132.38%-1.05M-130.21%-712.3K-47.67%-340.87K33.63%-78K96.01%-451.3K96.35%-309.42K95.98%-230.83K
-Interest Income (Financial expense) -108.95%-1.58M-30.26%-499.36K-192.01%-253.21K-127.25%-1.1M-125.98%-758.35K-53.34%-383.35K32.75%-86.71K95.80%-485.66K96.15%-335.58K95.70%-249.99K
Research and development -25.92%40.22M-41.42%24.83M-65.80%9.17M-22.76%77.73M-31.76%54.29M-14.14%42.38M59.10%26.8M-3.09%100.63M-1.14%79.56M-12.62%49.36M
Credit Impairment Loss 378.17%601.24K147.80%468.74K-109.88%-644.12K550.35%1.65M-138.22%-216.15K-1,807.96%-980.69K1,605.94%6.52M-76.01%253.23K-102.09%-90.73K-101.99%-51.4K
Asset Impairment Loss --------------0--------------0--------
Other net revenue -171.49%-140.02M-152.36%-138.92M-201,417.47%-230.64M-29.40%162.81M-19.98%195.87M12.59%265.34M-99.88%114.57K-30.79%230.63M284.04%244.77M546.67%235.67M
Fair value change income -169.70%-86.94M-153.93%-90.11M-1,970.60%-148.13M-20.05%100.27M-11.96%124.73M17.04%167.09M-110.16%-7.15M-32.45%125.41M465.12%141.68M560.31%142.76M
Invest income -177.10%-54.86M-150.88%-50.45M-12,408.75%-82.97M-31.03%59.81M-21.41%71.15M23.45%99.15M-96.73%674.1K-34.70%86.71M208.29%90.53M584.98%80.32M
-Including: Investment income associates -215.61%-70.92M-172.24%-65.85M-2,382.06%-90.93M-13.35%46.92M-9.84%61.35M30.04%91.16M-120.91%-3.66M-40.97%54.15M14,620.73%68.04M1,429.66%70.1M
Asset deal income -------------99.96%2.54K------------1.23%6.65M52.26%6.65M--6.65M
Other revenue 484.90%1.17M1,368.34%1.17M1,373.24%1.11M-90.60%1.09M-96.66%200.84K-98.68%79.38K-98.74%75.24K62.30%11.61M910.91%6.01M1,060.15%6M
Operating profit -156.13%-121.27M-146.54%-129.16M-9,424.25%-225.04M-52.19%121.74M-23.67%216.06M7.50%277.51M-98.00%2.41M-42.00%254.64M79.20%283.07M179.92%258.16M
Add:Non operating Income 965.63%330.63K358.86%130.22K----721.75%470.02K-43.97%31.03K15.06%28.38K250.48%24.76K-51.15%57.2K-50.65%55.37K-77.10%24.66K
Less:Non operating expense 3,016.88%566.77K52,876.07%526.77K1,065.87%1.1K-44.43%43.17K-76.59%18.18K-60.95%994.35-96.29%94.35-15.61%77.68K-34.81%77.68K82.79%2.55K
Total profit -156.23%-121.5M-146.68%-129.56M-9,329.95%-225.04M-52.02%122.16M-23.66%216.07M7.50%277.54M-97.98%2.44M-42.00%254.62M79.19%283.05M179.62%258.18M
Less:Income tax cost -184.68%-19.3M-176.06%-21.29M-1,709.22%-32.69M-50.44%25.76M-30.66%22.79M9.49%27.99M-86.58%2.03M18.40%51.97M31.45%32.86M150.18%25.57M
Net profit SL-102.21MSL-108.26MSL-192.35M-52.43%96.41M-22.74%193.29M7.28%249.54M-99.62%406.47K-48.71%202.65M88.17%250.18M183.28%232.61M
Net profit from continuing operation -152.88%-102.21M-143.38%-108.26M-47,421.38%-192.35M-52.43%96.41M-22.74%193.29M7.28%249.54M-99.62%406.47K-48.71%202.65M88.17%250.18M183.28%232.61M
Less:Minority Profit -23.70%-4.01M-46.93%-3.11M-314.00%-1.73M-212.23%-6.51M-32.65%-3.24M-34.93%-2.12M42.73%-417.47K70.78%-2.09M48.66%-2.44M51.26%-1.57M
Net profit of parent company owners -149.97%-98.2M-141.78%-105.15M-23,235.01%-190.62M-49.73%102.92M-22.21%196.53M7.47%251.66M-99.23%823.94K-49.11%204.73M83.44%252.62M174.43%234.18M
Earning per share
Basic earning per share -148.78%-0.2-142.31%-0.22-23,376.47%-0.3957-51.16%0.21-21.15%0.416.12%0.52-99.23%0.0017-48.81%0.4379.31%0.52172.22%0.49
Diluted earning per share -148.78%-0.2-142.31%-0.22-23,376.47%-0.3957-51.16%0.21-21.15%0.416.12%0.52-99.23%0.0017-48.81%0.4379.31%0.52172.22%0.49
Other composite income -135.49%-382.43K-83.08%221.22K113.28%61.7K-79.89%591.67K-70.21%1.08M-22.01%1.31M-238.16%-464.52K494.73%2.94M1,932.33%3.62M617.81%1.68M
Other composite income of parent company owners -135.49%-382.43K-83.08%221.22K113.28%61.7K-79.89%591.67K-70.21%1.08M-22.01%1.31M-238.16%-464.52K494.73%2.94M1,932.33%3.62M617.81%1.68M
Total composite income -152.78%-102.59M-143.07%-108.04M-331,112.04%-192.28M-52.82%97M-23.42%194.36M7.07%250.85M-100.05%-58.05K-47.87%205.59M91.17%253.8M186.45%234.29M
Total composite income of parent company owners -149.89%-98.58M-141.48%-104.93M-53,118.56%-190.56M-50.16%103.51M-22.88%197.6M7.26%252.97M-99.66%359.41K-48.28%207.68M86.33%256.24M177.45%235.86M
Total composite income of minority owners -23.70%-4.01M-46.93%-3.11M-314.00%-1.73M-212.23%-6.51M-32.65%-3.24M-34.93%-2.12M42.73%-417.47K70.78%-2.09M48.66%-2.44M51.26%-1.57M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Grant Tung Certified Public Accountants (Special General Partnership)------Grant Tung Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data